Zajicek, John

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 827

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Hobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007) · The Lancet Neurology

Psychometric Methodologies and TestingStatistical Methods in Clinical Trials

Cited by 495

Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease

Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Hagan, H., & Carroll, C. (2014) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 345

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Zajicek, J. P. (2005) · Journal of Neurology, Neurosurgery & Psychiatry

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 335

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort

Cossburn, M., Pace, A. A., Jones, J., Ali, R., Ingram, G., Baker, K., Hirst, C., Zajicek, J., Scolding, N., Boggild, M., et al. (2011) · Neurology

Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments

Cited by 216

Machine Learning-Based Method for Personalized and Cost-Effective Detection of Alzheimer's Disease

Escudero, J., Ifeachor, E., Zajicek, J. P., Green, C., Shearer, J., & Pearson, S. (2013) · IEEE Transactions on Biomedical Engineering

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare

Cited by 107